Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

23.53EUR
21 Jul 2017
Change (% chg)

€-0.22 (-0.95%)
Prev Close
€23.75
Open
€23.69
Day's High
€23.80
Day's Low
€23.42
Volume
375,159
Avg. Vol
736,093
52-wk High
€26.97
52-wk Low
€16.48

Latest Key Developments (Source: Significant Developments)

Grifols buys 44 pct stake in GigaGen for $35 mln
Wednesday, 5 Jul 2017 02:37am EDT 

July 5 (Reuters) - GRIFOLS SA ::SAYS BUYS 43.96 PERCENT SHAREHOLDING IN GIGAGEN INC FOR $35 MILLION.SAYS GIGAGEN TO CARRY OUT RESEARCH FOR GRIFOLS FOR A FEE OF $15 MILLION IN THERAPIES DERIVED FROM HUMAN B-CELLS.  Full Article

Grifols' unit to initiate phase II clinical trials of Alzheimer's vaccine
Tuesday, 27 Jun 2017 05:33am EDT 

June 27 (Reuters) - GRIFOLS SA ::SAYS ITS UNIT ARACLON BIOTECH RECEIVES APPROVAL TO INITIATE PHASE II CLINICAL TRIALS OF ITS ALZHEIMER'S VACCINE.  Full Article

Grifols enters into exclusive long-term distribution deal with Beckman Coulter
Monday, 12 Jun 2017 04:00am EDT 

June 12 (Reuters) - Grifols SA ::SAYS ENTERS INTO AN EXCLUSIVE LONG TERM DISTRIBUTION AGREEMENT WITH BECKMAN COULTER.  Full Article

Grifols to exclusively supply plasma derived products to US Ethicon inc‍​
Wednesday, 7 Jun 2017 01:40am EDT 

June 7 (Reuters) - GRIFOLS ::SAYS SIGNS AGREEMENT TO EXCLUSIVELY MANUFACTURE AND SUPPLY PLASMA DERIVED PRODUCTS FOR THE BIOSURGERY FIELD TO ETHICON INC‍​.SAYS AGREEMENT IS FOR AN INITIAL TERM OF 10 YEARS WITH SUBSEQUENT 5-YEAR RENEWAL PERIODS.SAYS AGREEMENT CALLS FOR THE PAYMENT OF CERTAIN MILESTONES UPON REGULATORY APPROVAL AND ANNUAL SALES BASED UPON FORECASTS.  Full Article

Grifols says its physiological saline gets approval from US FDA‍​
Monday, 5 Jun 2017 05:23am EDT 

June 5 (Reuters) - GRIFOLS ::SAYS ITS PHYSIOLOGICAL SALINE RECEIVES APPROVAL FROM THE US FOOD & DRUG ADMINISTRATION (FDA)‍​.  Full Article

Grifols proposes dividend of 0.11 eur/shr net
Friday, 26 May 2017 08:23am EDT 

May 26 (Reuters) - GRIFOLS SA ::PROPOSES DIVIDEND OF 0.11 EURO PER SHARE NET TO BE PAID ON JUNE 1.  Full Article

Grifols Q1 net profit up 7 pct YoY
Wednesday, 3 May 2017 02:27am EDT 

May 3 (Reuters) - Grifols SA ::Q1 net profit 134.0 million euros ($146.3 million) versus 125.2 million euros year ago.Q1 EBITDA 306.0 million euros versus 282.5 million euros year ago.Q1 net sales 1.06 billion euros versus 958.9 million euros year ago.  Full Article

Grifols says restated its 2005 agreement with Orasure Technologies
Monday, 24 Apr 2017 08:00am EDT 

April 24 (Reuters) - Grifols SA :Grifols - announces that it has restated its 2005 agreement with Orasure Technologies.Grifols - under terms of agreement, Grifols supplies antigens for Orasure's Oraquick HCV rapid antibody test.Grifols - company is currently building an $80 million, biological manufacturing facility in San Francisco bay area.Grifols - new Grifols manufacturing facility is expected to be completed in 2018.  Full Article

Grifols closes 1.00 bln euro bond issue, completes debt refinance process
Tuesday, 18 Apr 2017 09:07am EDT 

April 18 (Reuters) - Grifols SA ::Says closes 1.00 billion euro ($1.07 billion)issue of senior unsecured bonds due May 1st 2025, with annual coupon of 3,20 percent.Says proceeds will be used to refinance bond issued in March 2014 for $1.00 billion .Says completes debt restructuring process which began in January this year.  Full Article

Grifols launches repurchase offer for senior notes due 2022 for $1.00 bln
Thursday, 6 Apr 2017 07:46am EDT 

Grifols SA :Says its unit, Grifols Worldwide Operations Limited, has launched repurchase offer for senior notes due 2022 for $1.00 billion.  Full Article

BRIEF-Grifols buys 44 pct stake in GigaGen for $35 mln

* SAYS BUYS 43.96 PERCENT SHAREHOLDING IN GIGAGEN INC FOR $35 MILLION